Back
Intellia Therapeutics, Inc. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
16
NTLA
Intellia Therapeutics, Inc.
Last Price:
$9.75
Seasonality Move:
-7.2%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
Intellia Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.53 | Buy |
| 20-day SMA: | 9.18 | Sell |
| 50-day SMA: | 15.79 | Sell |
| 200-day SMA: | 11.42 | Sell |
| 8-day EMA: | 8.65 | Buy |
| 20-day EMA: | 10.03 | Sell |
| 50-day EMA: | 12.75 | Sell |
| 200-day EMA: | 13.33 | Sell |
Intellia Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.93 | Sell |
| Relative Strength Index (14 RSI): | 39.01 | Sell |
| Chaikin Money Flow: | 4215178 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.01 - 11.75) | Sell |
| Bollinger Bands (100): | (8.7 - 19.14) | Sell |
Intellia Therapeutics, Inc. Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics, Inc. Stock
Is Intellia Therapeutics, Inc. Stock a Buy?
-
Intellia Therapeutics, Inc. share price is 9.06 while NTLA 8-day simple moving average is 8.53, which is a Buy signal.
-
The stock price of NTLA is 9.06 while Intellia Therapeutics, Inc. 20-day SMA is 9.18, which makes it a Sell.
-
Intellia Therapeutics, Inc. 50-day simple moving average is 15.79 while NTLA share price is 9.06, making it a Sell technically.
-
NTLA stock price is 9.06 and Intellia Therapeutics, Inc. 200-day simple moving average is 11.42, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
16
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Is Intellia Therapeutics, Inc. a Buy or a Sell?
-
Intellia Therapeutics, Inc. stock is rated a SellThe current Intellia Therapeutics, Inc. [NTLA] share price is $9.06. The Score for NTLA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics, Inc. Stock Info
Market Cap:
1B
Price in USD:
9.06
Share Volume:
4.7M
Intellia Therapeutics, Inc. 52-Week Range
52-Week High:
28.25
52-Week Low:
5.90
Sell
16
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Intellia Therapeutics, Inc. Share Price Forecast
-
What is the Intellia Therapeutics, Inc. stock price today?The Intellia Therapeutics, Inc. stock price is 9.06 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics, Inc. is overvalued.
Is Intellia Therapeutics, Inc. Stock a Buy?
-
Intellia Therapeutics, Inc. share price is 9.06 while NTLA 8-day exponential moving average is 8.65, which is a Buy signal.
-
The stock price of NTLA is 9.06 while Intellia Therapeutics, Inc. 20-day EMA is 10.03, which makes it a Sell.
-
Intellia Therapeutics, Inc. 50-day exponential moving average is 12.75 while NTLA share price is 9.06, making it a Sell technically.
-
NTLA stock price is 9.06 and Intellia Therapeutics, Inc. 200-day simple moving average is 13.33, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics, Inc.
Is Intellia Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.36 per share.
Technical Analysis of Intellia Therapeutics, Inc.
Should I short Intellia Therapeutics, Inc. stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is -1.93, suggesting Intellia Therapeutics, Inc. is a Sell
-
Intellia Therapeutics, Inc. Relative Strength Index (RSI) is 39.01, which suggest Intellia Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Intellia Therapeutics, Inc. is (8.01 - 11.75), which suggest Intellia Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Intellia Therapeutics, Inc. is (8.7 - 19.14), which suggest Intellia Therapeutics, Inc. is a Sell
* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.